Wall Street brokerages predict that athenahealth, Inc (NASDAQ:ATHN) will announce $0.74 earnings per share for the current fiscal quarter, Zacks Investment Research reports. Twenty Two analysts have provided estimates for athenahealth’s earnings. The highest EPS estimate is $0.90 and the lowest is $0.38. athenahealth reported earnings of $0.32 per share during the same quarter last year, which would indicate a positive year-over-year growth rate of 131.3%. The firm is expected to announce its next quarterly earnings report after the market closes on Thursday, April 26th.
According to Zacks, analysts expect that athenahealth will report full year earnings of $3.79 per share for the current financial year, with EPS estimates ranging from $3.10 to $4.15. For the next year, analysts anticipate that the firm will post earnings of $4.49 per share, with EPS estimates ranging from $3.72 to $5.42. Zacks’ earnings per share calculations are an average based on a survey of sell-side research firms that that provide coverage for athenahealth.
athenahealth (NASDAQ:ATHN) last posted its quarterly earnings data on Thursday, February 1st. The health services provider reported $1.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.63 by $0.48. The business had revenue of $329.20 million during the quarter, compared to analyst estimates of $319.64 million. athenahealth had a return on equity of 9.21% and a net margin of 4.35%. The company’s revenue for the quarter was up 14.2% on a year-over-year basis. During the same period last year, the company earned $0.62 EPS.
Several equities research analysts have recently issued reports on the company. Royal Bank of Canada set a $141.00 price objective on athenahealth and gave the company a “hold” rating in a research note on Thursday, February 15th. SunTrust Banks raised their price target on athenahealth to $180.00 and gave the stock a “buy” rating in a research note on Monday, February 5th. BidaskClub lowered athenahealth from a “sell” rating to a “strong sell” rating in a research note on Saturday, February 3rd. Canaccord Genuity raised their price target on athenahealth from $123.00 to $137.00 and gave the stock a “hold” rating in a research note on Thursday, February 1st. Finally, Piper Jaffray reissued a “buy” rating and set a $160.00 price target on shares of athenahealth in a research note on Friday, February 16th. Three equities research analysts have rated the stock with a sell rating, seventeen have given a hold rating and seven have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $144.35.
NASDAQ:ATHN opened at $138.91 on Wednesday. The company has a market capitalization of $5,513.05, a PE ratio of 88.48, a P/E/G ratio of 2.88 and a beta of 1.13. athenahealth has a 1 year low of $95.01 and a 1 year high of $158.66. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.84 and a quick ratio of 1.84.
In other news, CEO Jonathan Bush sold 5,000 shares of athenahealth stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $122.69, for a total value of $613,450.00. Following the transaction, the chief executive officer now directly owns 320,807 shares in the company, valued at approximately $39,359,810.83. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Bradford Kyle Armbrester sold 2,235 shares of athenahealth stock in a transaction on Friday, March 2nd. The shares were sold at an average price of $138.70, for a total value of $309,994.50. Following the completion of the transaction, the senior vice president now owns 10,146 shares in the company, valued at $1,407,250.20. The disclosure for this sale can be found here. Insiders have sold a total of 47,555 shares of company stock worth $6,682,463 over the last 90 days. 3.20% of the stock is currently owned by company insiders.
Several large investors have recently made changes to their positions in the company. Fairfield Bush & CO. increased its holdings in shares of athenahealth by 154.4% in the 4th quarter. Fairfield Bush & CO. now owns 4,752 shares of the health services provider’s stock valued at $632,000 after acquiring an additional 2,884 shares during the period. Xact Kapitalforvaltning AB purchased a new position in shares of athenahealth in the 4th quarter valued at $537,000. LPL Financial LLC acquired a new stake in shares of athenahealth in the 4th quarter worth $207,000. Meadow Creek Investment Management LLC acquired a new stake in shares of athenahealth in the 4th quarter worth $132,000. Finally, Teachers Advisors LLC boosted its position in shares of athenahealth by 1.3% in the 4th quarter. Teachers Advisors LLC now owns 76,554 shares of the health services provider’s stock worth $10,185,000 after purchasing an additional 1,002 shares in the last quarter.
athenahealth Company Profile
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.